These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 27020037

  • 1. Investigation of the clinical significance of the growth hormone-releasing peptide-2 test for the diagnosis of secondary adrenal failure.
    Arimura H, Hashiguchi H, Yamamoto K, Shinnakasu A, Arimura A, Kikuchi A, Deguchi T, Habu M, Fujio S, Arita K, Nishio Y.
    Endocr J; 2016 Jun 30; 63(6):533-44. PubMed ID: 27020037
    [Abstract] [Full Text] [Related]

  • 2. Comparison of pituitary-adrenal responsiveness between insulin tolerance test and growth hormone-releasing peptide-2 test: a pilot study.
    Kano T, Sugihara H, Sudo M, Nagao M, Harada T, Ishizaki A, Nakajima Y, Tanimura K, Okajima F, Tamura H, Ishii S, Shibasaki T, Oikawa S.
    Peptides; 2010 Apr 30; 31(4):657-61. PubMed ID: 20045717
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests.
    Maghnie M, Uga E, Temporini F, Di Iorgi N, Secco A, Tinelli C, Papalia A, Casini MR, Loche S.
    Eur J Endocrinol; 2005 May 30; 152(5):735-41. PubMed ID: 15879359
    [Abstract] [Full Text] [Related]

  • 4. Concordant and discordant adrenocorticotropin (ACTH) responses induced by growth hormone-releasing peptide-2 (GHRP-2), corticotropin-releasing hormone (CRH) and insulin-induced hypoglycemia in patients with hypothalamopituitary disorders: evidence for direct ACTH releasing activity of GHRP-2.
    Kimura T, Shimatsu A, Arimura H, Mori H, Tokitou A, Fukudome M, Nakazaki M, Tei C.
    Endocr J; 2010 May 30; 57(7):639-44. PubMed ID: 20431231
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic usefulness of the growth hormone-releasing peptide-2 test as a substitute for the insulin tolerance test in hypopituitarism.
    Kageyama K, Nigawara T, Sakihara S, Takayasu S, Terui K, Moriyama T, Suda T.
    Endocr J; 2008 Aug 30; 55(4):777-83. PubMed ID: 18493103
    [Abstract] [Full Text] [Related]

  • 6. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec 30; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]

  • 7. Long-acting intramuscular ACTH stimulation test for the diagnosis of secondary adrenal insufficiency in children.
    Sharma R, Madathil S, Maheshwari V, Roy K, Kumar B, Jain V.
    J Pediatr Endocrinol Metab; 2019 Jan 28; 32(1):57-63. PubMed ID: 30530907
    [Abstract] [Full Text] [Related]

  • 8. Is the plasma ACTH concentration a reliable parameter in the insulin tolerance test?
    Borm K, Slawik M, Seiler L, Flohr F, Petrick M, Honegger J, Reincke M.
    Eur J Endocrinol; 2003 Dec 28; 149(6):535-41. PubMed ID: 14640994
    [Abstract] [Full Text] [Related]

  • 9. Diagnosis of adrenal insufficiency using the GHRP-6 Test: comparison with the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease.
    Alaioubi B, Mann K, Petersenn S.
    Horm Metab Res; 2010 Mar 28; 42(3):198-203. PubMed ID: 19946832
    [Abstract] [Full Text] [Related]

  • 10. CRH and lysine-vasopressin stimulation tests in the diagnosis of hypoadrenalism secondary to hypothalamic or pituitary disorders.
    Cantalamessa L, Catania A, Baldini M, Orsatti A, Motta P, Peracchi G.
    Horm Metab Res; 1990 Jul 28; 22(7):389-93. PubMed ID: 2169450
    [Abstract] [Full Text] [Related]

  • 11. Cortisol cut-points for the glucagon stimulation test in the evaluation of hypothalamic pituitary adrenal axis.
    Ach T, Yosra H, Jihen M, Abdelkarim Asma B, Maha K, Molka C, Rouatbi S, Monia Z, Ach K.
    Endocr J; 2018 Sep 27; 65(9):935-942. PubMed ID: 29952338
    [Abstract] [Full Text] [Related]

  • 12. Adrenocorticotropic hormone and cortisol response to corticotropin releasing hormone in the critically ill-a novel assessment of the hypothalamic-pituitary-adrenal axis.
    Schuster KM, Macleod JB, Fernandez JB, Kumar M, Barquist ES.
    Am J Surg; 2012 Feb 27; 203(2):205-10. PubMed ID: 21679920
    [Abstract] [Full Text] [Related]

  • 13. Diagnosis of adrenal insufficiency: Evaluation of the corticotropin-releasing hormone test and Basal serum cortisol in comparison to the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease.
    Schmidt IL, Lahner H, Mann K, Petersenn S.
    J Clin Endocrinol Metab; 2003 Sep 27; 88(9):4193-8. PubMed ID: 12970286
    [Abstract] [Full Text] [Related]

  • 14. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
    Thomas GB, Fairhall KM, Robinson IC.
    Endocrinology; 1997 Apr 27; 138(4):1585-91. PubMed ID: 9075719
    [Abstract] [Full Text] [Related]

  • 15. A comparison between the 1-microg adrenocorticotropin (ACTH) test, the short ACTH (250 microg) test, and the insulin tolerance test in the assessment of hypothalamo-pituitary-adrenal axis immediately after pituitary surgery.
    Dökmetaş HS, Colak R, Keleştimur F, Selçuklu A, Unlühizarci K, Bayram F.
    J Clin Endocrinol Metab; 2000 Oct 27; 85(10):3713-9. PubMed ID: 11061529
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of secondary adrenal insufficiency: findings by corticotropin-releasing hormone test and magnetic resonance imaging in parallel.
    Lin SY, Won JG, Lee TI, Tang KT, Lin HD.
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Apr 27; 65(4):156-63. PubMed ID: 12135194
    [Abstract] [Full Text] [Related]

  • 17. Plasma adrenocorticotropin and cortisol responses to ovine corticotropin-releasing factor in patients with adrenocortical insufficiency due to hypothalamic and pituitary disorders.
    Tsukada T, Nakai Y, Koh T, Tsujii S, Inada M, Nishikawa M, Shinoda H, Kawai I, Takezawa N, Imura H.
    J Clin Endocrinol Metab; 1984 Apr 27; 58(4):758-60. PubMed ID: 6321536
    [Abstract] [Full Text] [Related]

  • 18. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC, Nieman LK, Oldfield EH, Loughlin T, Barnes KM, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1989 May 27; 68(5):912-6. PubMed ID: 2541160
    [Abstract] [Full Text] [Related]

  • 19. A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency.
    Chihara K, Shimatsu A, Hizuka N, Tanaka T, Seino Y, Katofor Y, KP-102 Study Group.
    Eur J Endocrinol; 2007 Jul 27; 157(1):19-27. PubMed ID: 17609397
    [Abstract] [Full Text] [Related]

  • 20. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
    Gold PW, Kling MA, Khan I, Calabrese JR, Kalogeras K, Post RM, Avgerinos PC, Loriaux DL, Chrousos GP.
    Adv Biochem Psychopharmacol; 1987 Jul 27; 43():183-200. PubMed ID: 3035886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.